drugset / Trial / NCT02170012
A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study in healthy elderly people is to evaluate safety, toleration and time course of plasma concentration of multiple oral doses of PF-06743649- The pharmacodynamic activity of PF-06743649 will also be assessed.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-09
- Completion
- 2014-09
Outcome
Outcome not reported
Stopped: “The study was prematurely terminated on 17th December 2014 due to safety concerns.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06743649 | Unknown | 20 mg | Oral |
Indications
No indication recorded.